Kinvard Bio
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Raleigh, North Carolina, United StatesWebsite
www.kinvardbio.comRevenue
<$5 MillionIndustry
About Kinvard Bio
Kinvard Bio Org Chart
Co-founder & Director, Platform Development
Is Kinvard Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Kinvard Bio is spiking on competitors!
Product Launch: Get notified when Kinvard Bio launches new products
Funding: Get notified immidiatlly once Kinvard Bio has new funding data
Check if Kinvard Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Kinvard Bio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Kinvard Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Kinvard Bio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Kinvard Bio
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Kinvard Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kinvard Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kinvard Bio.
Kinvard Bio financials insights
Gather financial insights about Kinvard Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Grant
$2.7M
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kinvard Bio
Kinvard Bio is a biotechnology company advancing a differentiated, next generation class of antibiotics known as the oxepanoprolinamides (OPPs). OPPs exhibit broad-spectrum activity against multidrug-resistant Gram-positive and Gram-negative bacteria, as well as nontuberculous mycobacteria, and are designed to overcome resistance mechanisms that co... Read More